Search Within

Ryan Nathan Ptashkin

Formats
  1. Meeting Abstract (41)
  2. Journal Article (39)
  3. Research Letter (4)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (80)
  2. GSK Faculty (79)
  3. Human Oncology and Pathogenesis Program (76)
  4. Department of Medicine (74)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (69)
  6. Solid Tumor Oncology Division (59)

More Groups

People
  1. Michael Berger (53)
  2. Ahmet Zehir (50)
  3. Marc Ladanyi (42)
  4. Maria Arcila (31)
  5. Ross Levine (25)
  6. Ryma Benayed (23)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (10)
  4. 2022 (15)
  5. 2021 (8)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Modern Pathology (9)
  3. Blood (8)
  4. Clinical Cancer Research (8)
  5. Cancer Research (6)
  6. Journal of Molecular Diagnostics (6)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (13)
  3. Nature Publishing Group (12)
  4. American Society of Hematology (10)
  5. Nature Research (9)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chromosome 20q gain defines a molecular subtype associated with microsatellite stability, wild-type RAS/RAF, mutant TP53, left-sided tumors, and better overall survival in metastatic colorectal carcinoma
    Meeting Abstract

    Ptashkin, R. N.; Pagan, C.; Middha, S.; Yaeger, R.; Ladanyi, M.; Berger, M.; Zehir, A.; Hechtman, J. F.
    Journal of Molecular Diagnostics (2016)

    Fulltext@MSK | Save
  • Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion
    Journal Article

    Dogan, S.; Wang, L.; Ptashkin, R. N.; Dawson, R. R.; Shah, J. P.; Sherman, E. J.; Tuttle, R. M.; Fagin, J. A.; Klimstra, D. S.; Katabi, N.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • 20q gain is an oncogenic driver event that occurs preferentially in KRAS/ BRAF wild type colorectal carcinoma
    Meeting Abstract

    Pagan, C.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Shia, J. R.; Vakiani, E.; Ladanyi, M.; Hechtman, J.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Utility of oral fluid (saliva) for molecular profiling in hematologic malignancy
    Meeting Abstract

    Killian, J.; Arcila, M. E.; Batlevi, C.; Ladanyi, M.; Meltzer, P.; Ptashkin, R.; Younes, A.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • 20q gain is an oncogenic driver event that occurs preferentially in KRAS/BRAF wild type colorectal carcinoma
    Meeting Abstract

    Pagan, C.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Shia, J.; Vakiani, E.; Ladanyi, M.; Hechtman, J.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Utility of oral fluid (saliva) for molecular profiling in hematologic malignancy
    Meeting Abstract

    Killian, J.; Arcila, M. E.; Batlevi, C.; Ladanyi, M.; Meltzer, P.; Ptashkin, R.; Younes, A.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save